Forget Bitcoin! I’d rather get rich and retire early with cheap FTSE 100 stocks

Investing in Bitcoin could end up costing you a fortune, I think. You’d be much better trying to make a million today by buying FTSE 100 stocks.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Just as a high tide lifts all boats, shares all across the FTSE 100 have plummeted following the Covid-19 outbreak. Sure, the UK’s premier share index might have recovered strongly from the depths in late March. It’s currently up 25% from those decade-long lows. But there remain a whole load of great Footsie shares that remain wildly oversold.

To quote the legendary economist John Maynard Keynes: “Markets can remain irrational for longer than you can remain solvent.” But rather than grumble, I’d argue that the strange slump in many share prices provides an exceptional once-in-a-lifetime opportunity to grab some choice bargains.

The Bitcoin ‘gamble’

Ah, but wouldn’t I be better off using my money to buy into Bitcoin instead, you may ask? The virtual currency was washed out just like the FTSE 100 as coronavirus fears spread. But the bounceback here has been even more spectacular than that of the Footsie.

Since mid March Bitcoin has more than doubled from its Covid-19 troughs and was last trading around the $9,500 marker. Like the FTSE 100, crypto assets have benefitted from rising risk appetite as lockdown measures have been unwound in major economies, and central banks have continued printing money like it’s going out of fashion.

Could Bitcoin have further to go? It’s quite possible. I wouldn’t be surprised to see it double again by the autumn. However, I wouldn’t be shocked were it to halve in value over the period, either. And therein lies the problem with the new-age currency. It’s prone to wild price swings that on most occasions follow neither rhyme nor reason.

Screen of price moves in the FTSE 100

As I say, the FTSE 100 has been extremely choppy of late. But one can understand why share pickers are jittery. The global economy faces the biggest downturn since the 1930s, after all. Volatility in Bitcoin is common during both good times and bad. It removes the need for sound investor thinking and makes success or failure more of a question of mere timing and luck. I for one am not prepared to risk my hard-earned money on an asset class where shrewd decision making plays no part.

Some FTSE 100 bargains

Besides, at current prices there are a galaxy of FTSE 100 stocks I think are too cheap to miss. Some British blue chips carry the sort of low valuations that could turbocharge overall returns for long-term investors. So why take a chance with choppy Bitcoin?

Take GlaxoSmithKline as an example. This particular Footsie stock trades on a forward earnings multiple of just 14 times while it carries a monster 5% dividend yield for 2020, too. It’s in great shape to deliver big investor profits in the years ahead as a rising global population and booming healthcare spending in emerging regions drives demand for its drugs.

Or what about DS Smith? This FTSE 100 stalwart can expect demand for its environmentally friendly packaging to keep increasing as its critical e-commerce market steadily expands. And this big cap carries a price-to-earnings ratio of 11 times for 2020 and a bulky 4.5% dividend yield. But don’t worry if you don’t fancy either of these; there is a huge selection of cut-price Footsie shares to choose from at the moment.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Royston Wild owns shares of DS Smith. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended DS Smith. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »